GRI Bio Inc (GRI)
0.428
+0.03
(+6.81%)
USD |
NASDAQ |
May 16, 16:00
0.428
0.00 (0.00%)
After-Hours: 20:00
GRI Bio Total Assets (Quarterly): 4.587M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.587M |
December 31, 2023 | 2.956M |
September 30, 2023 | 4.404M |
Date | Value |
---|---|
June 30, 2023 | 5.642M |
March 31, 2023 | 2.097M |
December 31, 2022 | 0.383M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.383M
Minimum
Dec 2022
5.642M
Maximum
Jun 2023
3.345M
Average
3.68M
Median
Total Assets (Quarterly) Benchmarks
CEL-SCI Corp | 28.71M |
AIM ImmunoTech Inc | 19.38M |
IGC Pharma Inc | 11.26M |
NovaBay Pharmaceuticals Inc | 5.357M |
Protalix BioTherapeutics Inc | 89.82M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.789M |
Shareholders Equity (Quarterly) | 2.798M |